Cellect Biotechnology appoints chief development officer
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Cellect Biotechnology Ltd. appointed Yaron Pereg chief development officer.
Pereg fills the role vacated by Nadir Askenasy, who resigned as chief technology officer.
Pereg worked as senior director of oncology at BioLineRx Ltd. and held research and development positions at Genentech Inc.
